These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4036354)

  • 41. The Prevention Education Program (PEP) Nuremberg: design and baseline data of a family oriented intervention study.
    Ohrig E; Geiss HC; Haas GM; Schwandt P
    Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S89-92. PubMed ID: 11466597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [National Research Program 1A: course and overview of the health education campaign at Nyon].
    Soz Praventivmed; 1980 Nov; 25(5):287-92. PubMed ID: 7456754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal Lifestyle Components in Young Adulthood Are Associated With Maintaining the Ideal Cardiovascular Health Profile Into Middle Age.
    Gooding HC; Shay CM; Ning H; Gillman MW; Chiuve SE; Reis JP; Allen NB; Lloyd-Jones DM
    J Am Heart Assoc; 2015 Oct; 4(11):. PubMed ID: 26514160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project.
    Salonen JT; Puska P; Kottke TE; Tuomilehto J
    Am J Epidemiol; 1981 Jul; 114(1):81-94. PubMed ID: 6972694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physical activity and biological risk factors clustering in pediatric population.
    Ribeiro JC; Guerra S; Oliveira J; Teixeira-Pinto A; Twisk JW; Duarte JA; Mota J
    Prev Med; 2004 Sep; 39(3):596-601. PubMed ID: 15313100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pravastatin for cardiovascular event primary prevention in patients with mild-to-moderate hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
    Kushiro T; Mizuno K; Nakaya N; Ohashi Y; Tajima N; Teramoto T; Uchiyama S; Nakamura H;
    Hypertension; 2009 Feb; 53(2):135-41. PubMed ID: 19104004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Epidemiology of risk factors for cardiovascular disease in Switzerland].
    Billo NE; Gutzwiller F
    Schweiz Med Wochenschr Suppl; 1984; 16():6-10. PubMed ID: 6588552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A community-based participatory diabetes prevention and management intervention in rural India using community health workers.
    Balagopal P; Kamalamma N; Patel TG; Misra R
    Diabetes Educ; 2012; 38(6):822-34. PubMed ID: 23033123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey.
    Arnett DK; McGovern PG; Jacobs DR; Shahar E; Duval S; Blackburn H; Luepker RV
    Am J Epidemiol; 2002 Nov; 156(10):929-35. PubMed ID: 12419765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The value of continued follow-up in a preventive medicine program.
    Villafana C; Mockbee J
    IMS Ind Med Surg; 1971 Jul; 40(4):11-5. PubMed ID: 5289732
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.
    Santschi V; Chiolero A; Burnand B; Colosimo AL; Paradis G
    Arch Intern Med; 2011 Sep; 171(16):1441-53. PubMed ID: 21911628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diet and lifestyle guidelines and desirable levels of risk factors for the prevention of diabetes and its vascular complications in Indians: a scientific statement of The International College of Nutrition. Indian Consensus Group for the Prevention of Diabetes.
    Singh RB; Rastogi SS; Rao PV; Das S; Madhu SV; Das AK; Sahay BK; Fuse SM; Beegom R; Sainani GS; Shah NA
    J Cardiovasc Risk; 1997 Jun; 4(3):201-8. PubMed ID: 9475675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The North Karelia Project: a programme for community control of cardiovascular diseases.
    Puska P; Koskela K; Pakarinen H; Puumalainen P; Soininen V; Tuomilehto J
    Scand J Soc Med; 1976; 4(2):57-60. PubMed ID: 959783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of cardiovascular risk factors in Lithuanian middle-aged subjects participating in the primary prevention program, analysis of the period 2009-2012.
    Laucevičius A; Rinkūnienė E; Skujaitė A; Petrulionienė Ž; Puronaitė R; Dženkevičiūtė V; Kasiulevičius V; Jatužis D; Ryliškytė L; Šlapikas R
    Blood Press; 2015 Feb; 24(1):41-7. PubMed ID: 25268930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cardiovascular prevention in a change of era].
    Vanuzzo D; Giampaoli S; Fedele F; Mercuro G; Gulizia MM; Romeo F; Gabrielli D; Di Lenarda A
    G Ital Cardiol (Rome); 2017; 18(7):541-546. PubMed ID: 28714996
    [No Abstract]   [Full Text] [Related]  

  • 56. [Swiss National Research Program on the Prevention of Cardiovascular Disease: examination of initial health].
    Junod B; Gutzwiller F
    Schweiz Med Wochenschr Suppl; 1981; 12():suppl 8-14. PubMed ID: 6943674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role development of community health workers for cardiovascular disease prevention in India.
    Khetan A; Patel T; Hejjaji V; Barbhaya D; Mohan SKM; Josephson R; Webel A
    Eval Program Plann; 2018 Apr; 67():177-183. PubMed ID: 29407939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Trends and current questions of cardiovascular prevention in primary health care].
    Ilyés I; Jancsó Z; Simay A
    Orv Hetil; 2012 Sep; 153(39):1536-46. PubMed ID: 23000420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton.
    Bovet P; Hirsiger P; Emery F; De Bernardini J; Rossier C; Trebeljahr J; Hagon-Traub I
    Diabetes Metab Syndr Obes; 2011; 4():213-23. PubMed ID: 21760738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.
    John EJ; Vavra T; Farris K; Currie J; Doucette W; Button-Neumann B; Osterhaus M; Kumbera P; Halterman T; Bullock T
    Pharmacotherapy; 2006 Oct; 26(10):1511-7. PubMed ID: 16999661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.